BeautyHealth Reports First Quarter 2024 Financial Results
Delivers first quarter net sales of $81.4 million; year-over-year operating expense improvement of $6.1 million Repurchases $192.3 million of convertible...
Delivers first quarter net sales of $81.4 million; year-over-year operating expense improvement of $6.1 million Repurchases $192.3 million of convertible...
ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their...
Showcased 20 presentations at the 27th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting demonstrating progression of neurology-focused...
SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology...
Reports 17% Revenue Increase, ARR of $16.6 MillionPositive Net Income and Record Adjusted EBITDA HENDERSON, Nev., May 9, 2024 /PRNewswire/...
Contacts Connie Kao Group Vice President, Investor & Media Relations (925) 965-4668 connie.kao@ros.com Ross Stores, Inc. (NASDAQ: ROST) plans to...
Initiation of global Phase 3 HARBOR™ trial for del-desiran (AOC 1001) in DM1 on track for this quarter Avidity to report FSHD...
HOUSTON, May 9, 2024 /PRNewswire/ -- RCI Hospitality Holdings, Inc. (Nasdaq: RICK) today reported results for the fiscal 2024 second...
BERKELEY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in...
BERKELEY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in...
Initiated the fourth cohort of patients in the Phase 1b multiple-ascending dose (MAD) clinical trial of RGLS8429 for the treatment...
Executed Full Commercial Launch of Platinum® Instrument Reaffirms Full Year 2024 Financial Guidance Contacts Investor Contact Jeff Keyes, Chief Financial...
Double-Digit Growth in Gross Profit Resulting from Business Expansion and Efficiency GainsSignificant New Business Wins and Pipeline Growth Reflect Company’s...
Raising Full Year Revenue and Operating Margin Guidance Contacts Investor Relations: Deborah R. Gordon Vice President, Investor Relations (978) 600-7717...
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading...
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or the “Company”), the leading provider of...
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family...
SANTA CLARA, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data...
Contacts (INVESTORS) Wayne Wasechek 509-835-1521 (MEDIA) Anna Torma 509-835-1558 The board of directors of PotlatchDeltic Corporation (Nasdaq: PCH) declared a...
MENLO PARK, Calif., May 9, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31,...
GRAND CAYMAN, Cayman Islands, May 09, 2024 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), which together...
GRAND CAYMAN, Cayman Islands, May 09, 2024 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), which together...
MINNEAPOLIS, May 09, 2024 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (OTCQX: AATC) today announced results for its quarter ended March...
MONMOUTH JUNCTION, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced...
Net Revenue of $80.6 million, an increase of 16.1% year-over-yearCash Flow from operations of $13.3 million and Free Cash Flow1...
EXETER, N.H., May 9, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced first quarter 2024...
CANTON, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on...
Pelareorep advancing to registration-enabling studies Preparations underway for Type C meeting with the FDA to establish registrational pathway in HR+/HER2-...
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
TORRANCE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation power semiconductors, today...
Contacts Investor Relations Mike Brophy, CFO, Natera, Inc., 510-826-2350 Media Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com Natera,...
SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered...
THORNTON, Colo., May 09, 2024 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading...
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents...
Reduces Operating Expense by over $5 million and Net Loss by over 50% compared to 2023 TAMPA, Fla., May 9,...
Contacts For Media: media@mindmed.co For Investors: ir@mindmed.co Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage...
Contacts FGS Global Maiden@fgsglobal.com Maiden Holdings, Ltd. (NASDAQ:MHLD) ("Maiden") has released its first quarter 2024 financial results via its investor...
ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing...
-- Ongoing Phase 1 Study Evaluating Voruciclib Plus Venetoclax Demonstrates Anti-leukemic Activity, Including Complete Responses, Anticipated Decreases in Mcl-1 and...
Active clinical trials across three AI-guided drug candidates with initial data and clinical readouts for LP-184 on-track for the second...